Therapeutic Efficacy of Nanodrug Delivery Compared With Current Nonsurgical Treatments for Patients With Cutaneous Melanoma: A Systematic Review. [PDF]
Hussain Z +4 more
europepmc +1 more source
Study of brentuximab vedotin combination treatment in people with early-stage Hodgkin lymphoma: a plain language summary. [PDF]
Abramson JS +20 more
europepmc +1 more source
Interim Positron Emission Tomography-Adapted Treatment Strategies for Classic Hodgkin Lymphoma: Insights From Korean Real-World Data. [PDF]
Byeon S +6 more
europepmc +1 more source
Advances in First-Line Treatment of Classical Hodgkin Lymphoma in the Era of Novel Agents. [PDF]
Barefah AS.
europepmc +1 more source
Nivolumab-AVD versus Brentuximab Vedotin-AVD as First-Line Treatment for Advanced-Stage Classical Hodgkin Lymphoma: A Cost-Effectiveness Analysis. [PDF]
Li B, Yang J, Li J, Huang J, Li Z.
europepmc +1 more source
Advanced Stage Hodgkin Lymphoma: A Review on Frontline Treatment Advances. [PDF]
Baron K, Hu B.
europepmc +1 more source
Evaluating the potential of candidate surrogate endpoints for overall survival in treatment-naive metastatic melanoma treated with anti-PD-1-based regimens with or without anti-CTLA-4 therapy. [PDF]
Squifflet P +6 more
europepmc +1 more source
Role of CTLA-4 blockade and dacarbazine therapy following anti-PD-1 resistance in melanoma. [PDF]
Urbonas V, Dulskas A.
europepmc +1 more source
AVD for older patients with classical Hodgkin lymphoma. [PDF]
Marconi T, Ratnasingam S.
europepmc +1 more source
Hodgkin lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up. [PDF]
Eichenauer DA +17 more
europepmc +1 more source

